Committees

Market Access & Patient Advocacy Subcommittee

Charter

The Market Access & Patient Advocacy Subcommittee strives to:

    • educate the cell therapy industry on challenges associated with getting cell and gene therapies to patients. This includes topics on patient advocacy, access to clinical trials, and reimbursement considerations.

    The Committee

    Headshot of Gerhard Bauer

    Chair

    Gerhard Bauer, PhD

    UC Davis
    United States

    Members

    Miguel Forte, MD, PhD
    Bone Therapeutics
    Brussels, Belgium

    Lynn Gallant
    BlueRock Therapeutics
    Cambridge, MA, United States

    David Keen
    EcoLab, Bioquell
    United States

    Michaela Malchow
    Miltenyi
    Germany

    Chris McClain
    Be The Match BioTherapies
    United States

    Siofradh McMahon
    CCRM
    Canada

    Shikha Mishra
    Thermo Fisher Scientific
    United States

    Erika Siren, PhD
    Takeda
    United States

    Jenny Stjernberg
    ScaleReady
    Sweden

    View All Committees